{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:30:41Z","timestamp":1783647041925,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1023\/b:drug.0000006177.46798.1f","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T09:47:41Z","timestamp":1070358461000},"page":"75-81","source":"Crossref","is-referenced-by-count":22,"title":["Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group"],"prefix":"10.1007","volume":"22","author":[{"given":"Keith","family":"Stuart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna E.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Axiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice P.","family":"Dutcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Erban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Al Bowen","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"4","key":"5151117_CR1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","volume":"79","author":"IM Modlin","year":"1997","unstructured":"Modlin IM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 79(4): 813\u2013829, 1997","journal-title":"Cancer"},{"issue":"5B","key":"5151117_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(87)90422-0","volume":"82","author":"W Creutzfeldt","year":"1987","unstructured":"Creutzfeldt W, Stockmann F: Carcinoids and carcinoid syndrome. Am J Med 82(5B): 4\u201316, 1987","journal-title":"Am J Med"},{"issue":"11","key":"5151117_CR3","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","volume":"340","author":"MH Kulke","year":"1999","unstructured":"Kulke MH, Mayer RJ: Carcinoid tumors. N Engl J Med 340(11): 858\u2013868, 1999","journal-title":"N Engl J Med"},{"key":"5151117_CR4","doi-asserted-by":"crossref","unstructured":"Moertel CG: Kamofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 5(10): 1502\u20131522","DOI":"10.1200\/JCO.1987.5.10.1502"},{"issue":"3","key":"5151117_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000201195","volume":"55","author":"W Creutzfeldt","year":"1994","unstructured":"Creutzfeldt W: Historical background and natural history of carcinoids. Digestion 55(3): 3\u201310, 1994","journal-title":"Digestion"},{"issue":"6","key":"5151117_CR6","first-page":"1111","volume":"116","author":"LJ Perry","year":"1994","unstructured":"Perry LJ et al.: Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 116(6): 1111\u20131116; discussion 1116\u20131117, 1994","journal-title":"Surgery"},{"issue":"11","key":"5151117_CR7","first-page":"1297","volume":"70","author":"K Oberg","year":"1986","unstructured":"Oberg K et al.: Treatment of malignant carcinoid tumors with human leukocyte interferon: Long-term results. Cancer Treat Rep 70(11): 1297\u20131304, 1986","journal-title":"Cancer Treat Rep"},{"issue":"7","key":"5151117_CR8","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.4049\/jimmunol.139.7.2414","volume":"139","author":"JM Carlin","year":"1987","unstructured":"Carlin JM et al.: Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures. J Immunol 139(7): 2414\u20132418, 1987","journal-title":"J Immunol"},{"key":"5151117_CR9","unstructured":"Markman M: Models for the antitumor action of interferon against human ovarian cancer. Annual Meeting of the International Society for Interferon Research, 1991"},{"issue":"4","key":"5151117_CR10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1073\/pnas.85.4.1242","volume":"85","author":"Y Ozaki","year":"1988","unstructured":"Ozaki Y, Edelstein MP, Duch DS: Induction of indoleamine 2,3-dioxygenase: A mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci USA 85(4): 1242\u20131246, 1988","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"5151117_CR11","first-page":"346","volume":"48","author":"LM de la Maza","year":"1988","unstructured":"de la Maza LM, Peterson EM: Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media. Cancer Res 48(2): 346\u2013350, 1988","journal-title":"Cancer Res"},{"issue":"4","key":"5151117_CR12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","volume":"263","author":"O Takikawa","year":"1988","unstructured":"Takikawa O et al.: Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J Biol Chem 263(4): 2041\u20132048, 1988","journal-title":"J Biol Chem"},{"key":"5151117_CR13","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment. Geneva (Switzerland): World Health Organization Offset Publication No. 48; 1979"},{"key":"5151117_CR14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL: Nonparametric estimation of incomplete observations. J Amer Statist Assoc 53: 457\u2013481, 1958","journal-title":"J Amer Statist Assoc"},{"issue":"1","key":"5151117_CR15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1365-2141.1991.tb08125.x","volume":"79","author":"K Oberg","year":"1991","unstructured":"Oberg K, Eriksson B: The role of interferons in the management of carcinoid tumours. Br J Haematol 79(1): 74\u201377, 1991","journal-title":"Br J Haematol"},{"issue":"5","key":"5151117_CR16","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1634\/theoncologist.3-5-339","volume":"3","author":"K Oberg","year":"1998","unstructured":"Oberg K: Carcinoid tumors: Current Concepts in Diagnosis and Treatment. Oncologist 3(5): 339\u2013345, 1998","journal-title":"Oncologist"},{"issue":"2","key":"5151117_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00001813-199603000-00005","volume":"7","author":"LY Dirix","year":"1996","unstructured":"Dirix LY et al.: Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors -an antiangiogenic effect? Anti-Cancer Drugs 7(2): 175\u2013181, 1996","journal-title":"Anti-Cancer Drugs"},{"issue":"2","key":"5151117_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/02841869309083918","volume":"32","author":"M Di Bartolomeo","year":"1993","unstructured":"Di Bartolomeo M et al.: Treatment of carcinoid syndrome with recombinant interferon alpha-2a. Acta Oncol 32(2): 235\u2013238, 1993","journal-title":"Acta Oncol"},{"key":"5151117_CR19","doi-asserted-by":"crossref","unstructured":"Joensuu H, Kumpulainen E, Grohn P: Treatment of metastatic carcinoid tumour with recombinant interferon alfa. Eur J Cancer 28A(10): 1650\u20131653","DOI":"10.1016\/0959-8049(92)90061-6"},{"issue":"3","key":"5151117_CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/1097-0142(19910201)67:3<547::AID-CNCR2820670302>3.0.CO;2-J","volume":"67","author":"M Valimaki","year":"1991","unstructured":"Valimaki M et al.: Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested? Cancer. 67(3): 547\u2013549, 1991","journal-title":"Cancer"},{"issue":"2","key":"5151117_CR21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/02841869309083917","volume":"32","author":"ET Janson","year":"1993","unstructured":"Janson ET, Kauppinen HL, Oberg K: Combined alpha-and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I\u2013II trial. Acta Oncol 32(2): 231\u2013233, 1993","journal-title":"Acta Oncol"},{"issue":"2","key":"5151117_CR22","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4","volume":"77","author":"M di Bartolomeo","year":"1996","unstructured":"di Bartolomeo M, et al.: Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group. Cancer 77(2): 402\u20138, 1996","journal-title":"Cancer"},{"issue":"2","key":"5151117_CR23","first-page":"184","volume":"126","author":"H Joensuu","year":"1992","unstructured":"Joensuu H, Katka K, Kujari H: Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotide. Acta Endocrinol (Copenh) 126(2): 184\u2013185, 1992","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"2","key":"5151117_CR24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/02841869309083916","volume":"32","author":"ET Janson","year":"1993","unstructured":"Janson ET, Oberg K: Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon. Acta Oncol 32(2): 225\u2013229, 1993","journal-title":"Acta Oncol"},{"issue":"6","key":"5151117_CR25","first-page":"583","volume":"67","author":"GA van Hazel","year":"1983","unstructured":"van Hazel GA, Rubin J, Moertel CG: Treatment of metastatic carcinoid tumor with dactinomycin or dacarbazine. Cancer Treat Rep 67(6): 583\u2013585, 1983","journal-title":"Cancer Treat Rep"},{"issue":"11","key":"5151117_CR26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1200\/JCO.1984.2.11.1255","volume":"2","author":"PF Engstrom","year":"1984","unstructured":"Engstrom PF et al.: Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor. J Clin Oncol 2(11): 1255\u20131259, 1984","journal-title":"J Clin Oncol"},{"issue":"11","key":"5151117_CR27","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/00007611-197211000-00005","volume":"65","author":"JM Feldman","year":"1972","unstructured":"Feldman JM et al.: Streptozotocin treatment of metastatic carcinoid tumors. South Med J 65(11): 1325\u20131327, 1972","journal-title":"South Med J"},{"issue":"2","key":"5151117_CR28","first-page":"164","volume":"65","author":"FI Iweze","year":"1972","unstructured":"Iweze FI, Owen-Smith M, Polak J: Carcinoid syndrome treated with streptozotocin. Proc R Soc Med 65(2): 164\u2013165, 1972","journal-title":"Proc R Soc Med"},{"issue":"11","key":"5151117_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.1983.1.11.727","volume":"1","author":"CG Moertel","year":"1983","unstructured":"Moertel CG: Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1(11): 727\u2013740, 1983","journal-title":"J Clin Oncol"},{"issue":"12","key":"5151117_CR30","first-page":"1459","volume":"70","author":"CG Moertel","year":"1986","unstructured":"Moertel CG, Rubin J, O'Connell MJ: Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Treat Rep 70(12): 1459\u20131460, 1986","journal-title":"Cancer Treat Rep"},{"issue":"5","key":"5151117_CR31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/1097-0142(19940301)73:5<1505::AID-CNCR2820730530>3.0.CO;2-V","volume":"73","author":"RM Bukowski","year":"1994","unstructured":"Bukowski RM et al.: Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoid. A Southwest Oncology Group study. Cancer 73(5): 1505\u20131508, 1994","journal-title":"Cancer"},{"issue":"12","key":"5151117_CR32","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/1097-0142(19871215)60:12<2891::AID-CNCR2820601207>3.0.CO;2-6","volume":"60","author":"RM Bukowski","year":"1987","unstructured":"Bukowski RM et al.: A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study. Cancer 60(12): 2891\u20132895, 1987","journal-title":"Cancer"},{"issue":"5","key":"5151117_CR33","first-page":"795","volume":"63","author":"D Chernicoff","year":"1979","unstructured":"Chernicoff D et al.: Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin. Cancer Treat Rep 63(5): 795\u2013796, 1979","journal-title":"Cancer Treat Rep"},{"issue":"4","key":"5151117_CR34","first-page":"327","volume":"2","author":"CG Moertel","year":"1979","unstructured":"Moertel CG, Hanley JA: Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome. Cancer Clin Trials 2(4): 327\u2013334, 1979","journal-title":"Cancer Clin Trials"},{"issue":"5","key":"5151117_CR35","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/1120009X.1991.11739114","volume":"3","author":"R Ridolfi","year":"1991","unstructured":"Ridolfi R et al.: Chemotherapy with 5-fluorouracil and streptozotocin in carcinoid tumors of gastrointestinal origin: Experiences with 13 patients. J Chemother 3(5): 328\u2013331, 1991","journal-title":"J Chemother"},{"issue":"6","key":"5151117_CR36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1200\/JCO.1995.13.6.1486","volume":"13","author":"HJ Andreyev","year":"1995","unstructured":"Andreyev HJ et al.: Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors. J Clin Oncol 13(6): 1486\u20131492, 1995","journal-title":"J Clin Oncol"},{"issue":"9","key":"5151117_CR37","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1023\/A:1012272314550","volume":"12","author":"PF Quaedvlieg","year":"2001","unstructured":"Quaedvlieg PF et al.: Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol 12(9): 1295\u20131300, 2001","journal-title":"Ann Oncol"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DRUG.0000006177.46798.1f.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:DRUG.0000006177.46798.1f\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:DRUG.0000006177.46798.1f.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T20:05:50Z","timestamp":1753819550000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:DRUG.0000006177.46798.1f"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["5151117"],"URL":"https:\/\/doi.org\/10.1023\/b:drug.0000006177.46798.1f","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}